British Patient Capital has announced a €28m commitment to ETF Partners’ Fourth Fund, which focuses on investing in early-growth stage companies addressing climate-related challenges through technological innovation. The investment is part of a broader €260m fund, also backed by the European Investment Fund and other investors. This additional funding will support ETF Partners in its mission to foster sustainable innovation and help scale up businesses like Dexter, Net Purpose, Fairly Made, Open Cosmos, and Hellas Direct, all of which are tackling various environmental issues.

Venture Capital, Sustainability, Technology,United Kingdom, Europe